We are a leading global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. We entered the life sciences market in 2011, leveraging our in-house precision automation and cryogenics capabilities that we were then applying in the semiconductor manufacturing market. This led us to develop and provide solutions for automated ultra-cold storage. Since then, we have expanded our life sciences offerings through internal investments and through a series of acquisitions. We support our customers from research and clinical development to commercialization with our sample management and automated storage systems, as well as genomic services expertise to help our customers bring impactful therapies to market faster.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 595M | 594M | 573M | 551M | - | 514M |
| Net Income | -58M | -56M | -165M | -15M | 2.1B | 111M |
| EPS | $-1.26 | $-1.22 | $-3.10 | $-0.22 | $28.48 | $1.49 |
| Free Cash Flow | 31M | 38M | 12M | -34M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 483M | 553M | 434M | 527M | 632M | 334M | 389M | 514M | N/A | 551M | 573M | 594M | 595M |
| Gross Margin | 34.7% | 34.2% | 36.1% | 37.7% | 39.0% | 40.3% | 44.3% | 47.5% | N/A | 43.4% | 44.4% | 45.5% | 44.6% |
| R&D | 53M | 52M | 44M | 40M | 47M | 17M | 18M | 22M | 28M | 32M | 32M | 30M | 33M |
| SG&A | 111M | 115M | 119M | 142M | 167M | 163M | 190M | 252M | 251M | 264M | 263M | 262M | 249M |
| EBIT | -2.7M | 17M | -17M | 14M | 31M | -47M | -37M | -31M | N/A | -61M | -51M | -27M | -23M |
| Op. Margin | -0.6% | 3.1% | -3.9% | 2.7% | 5.0% | -14.2% | -9.4% | -6.1% | N/A | -11.1% | -8.9% | -4.5% | -3.8% |
| Net Income | 31M | 14M | -69M | 63M | 117M | 437M | 65M | 111M | 2.1B | -15M | -165M | -56M | -58M |
| Net Margin | 6.5% | 2.6% | -16.0% | 11.9% | 18.5% | 130.9% | 16.7% | 21.6% | N/A | -2.7% | -28.8% | -9.4% | -9.7% |
| Non-Recurring | 6.3M | 4.7M | 10M | 3.6M | 1.5M | 410M | 355K | -563K | 2.1B | 4.6M | 118M | 4.5M | 5.9M |
| Returns on Capital | |||||||||||||
| ROIC | 4.9% | 2.6% | -3.3% | 10.8% | 15.3% | 41.6% | 5.3% | 8.4% | N/A | -0.5% | -3.3% | -3.3% | -2.2% |
| ROE | 4.9% | 2.2% | -11.7% | 10.8% | 17.6% | 47.1% | 5.5% | 8.7% | 91.0% | -0.5% | -7.8% | -3.3% | -3.4% |
| ROA | 4.1% | 1.9% | -9.6% | 8.6% | 12.5% | 33.5% | 4.2% | 6.6% | 77.1% | -0.4% | -6.7% | -2.7% | -2.8% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 54M | 44M | 40M | 96M | 74M | 91M | 38M | 150M | -466M | 5.8M | 50M | 72M | 62M |
| Free Cash Flow | 48M | 28M | 27M | 84M | 61M | 67M | -2.1M | 97M | -539M | -34M | 12M | 38M | 31M |
| Owner Earnings | 19M | 6.4M | -236K | 51M | 17M | -80M | -44M | 57M | -530M | -89M | -55M | -9.9M | -14M |
| CapEx | 5.5M | 16M | 13M | 13M | 13M | 24M | 40M | 53M | 73M | 39M | 37M | 34M | 31M |
| Maint. CapEx | 23M | 25M | 28M | 28M | 37M | 151M | 65M | 65M | 54M | 86M | 91M | 61M | 57M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20M | 0 | 0 | 0 | 0 |
| D&A | 23M | 25M | 28M | 28M | 37M | 151M | 65M | 65M | 54M | 86M | 91M | 61M | 57M |
| CapEx/OCF | 10.3% | 36.9% | 32.5% | 13.2% | 17.3% | 26.3% | 105.4% | 35.2% | N/A | 550.9% | 75.2% | 46.9% | 50.4% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 23M | 27M | 28M | 28M | 28M | 29M | 30M | 30M | 7.5M | 0 | 0 | 0 | 0 |
| Dividend Yield | 3.8% | 3.9% | 3.9% | 1.9% | 1.4% | 1.2% | 1.0% | 0.5% | 0.1% | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 839M | 662M | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 26.1% | 25.2% | N/A | 0.0% |
| Stock-Based Comp | 11M | 12M | 12M | 17M | 20M | 20M | 16M | 27M | 11M | 9.4M | 14M | 21M | 20M |
| Debt Repayment | 0 | 0 | 708K | 28K | 1.5M | 687K | 0 | 0 | 50M | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | N/A | N/A | -55M | -242M | -203M | -181M | -1.9B | -1.1B | -479M | -541M | -908M |
| Cash & Equiv. | 94M | 81M | 85M | 102M | 198M | 257M | 251M | 227M | 658M | 649M | 280M | 280M | 908M |
| Long-Term Debt | N/A | N/A | N/A | N/A | 194M | 50M | 50M | 50M | 98K | 1.4M | 975K | 903K | 903K |
| Debt/Equity | 0.21 | 0.20 | 0.24 | 0.26 | 0.27 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | -13.4 | 42.8 | -108.6 | 35.1 | 3.3 | -2.1 | -12.4 | -15.3 | N/A | -1531.2 | -576.2 | N/A | N/A |
| Equity | 643M | 632M | 554M | 608M | 718M | 1.1B | 1.2B | 1.3B | 3.4B | 2.5B | 1.7B | 1.7B | 1.7B |
| Total Assets | 778M | 759M | 686M | 767M | 1.1B | 1.5B | 1.6B | 1.8B | 3.7B | 2.9B | 2.0B | 2.0B | 2.1B |
| Total Liabilities | 135M | 127M | 132M | 159M | 377M | 377M | 346M | 494M | 353M | 351M | 323M | 339M | 360M |
| Intangibles | 60M | 55M | 82M | 84M | 100M | 251M | 212M | 187M | 178M | 294M | 125M | 102M | 97M |
| Retained Earnings | -1.0B | -1.0B | -1.1B | -1.1B | -994M | -586M | -551M | -470M | 1.7B | 1.6B | 1.5B | 1.4B | 1.4B |
| Working Capital | 260M | 243M | 180M | 205M | 399M | 375M | 438M | 432M | 2.2B | 1.2B | 645M | 489M | 513M |
| Current Assets | 374M | 356M | 299M | 352M | 564M | 647M | 649M | 777M | 2.5B | 1.4B | 848M | 710M | 780M |
| Current Liabilities | 114M | 113M | 120M | 147M | 165M | 272M | 211M | 345M | 231M | 211M | 203M | 221M | 267M |
| Per Share Data | |||||||||||||
| EPS | 0.46 | 0.21 | -1.01 | 0.89 | 1.64 | 6.04 | 0.88 | 1.49 | 28.48 | -0.22 | -3.10 | -1.22 | -1.26 |
| Owner EPS | 0.28 | 0.09 | -0.00 | 0.72 | 0.24 | -1.10 | -0.60 | 0.77 | -7.08 | -1.34 | -1.04 | -0.22 | -0.31 |
| Book Value | 9.43 | 9.33 | 8.05 | 8.64 | 10.10 | 15.73 | 16.47 | 17.83 | 44.91 | 38.09 | 32.34 | 37.09 | 37.26 |
| Cash Flow/Share | 0.79 | 0.65 | 0.57 | 1.37 | 1.04 | 1.26 | 0.51 | 2.02 | -6.22 | 0.09 | 0.94 | 1.58 | -0.02 |
| Dividends/Share | 0.34 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.10 | 0.00 | 0.00 | N/A | 0.00 |
| Shares Out. | 68.2M | 67.7M | 68.8M | 70.4M | 71.1M | 72.4M | 73.7M | 74.3M | 74.9M | 66.5M | 53.2M | 45.7M | 46.0M |
| Valuation | |||||||||||||
| P/E Ratio | 20.5 | 46.2 | N/A | 32.4 | 20.8 | 6.0 | 52.3 | 70.6 | 1.6 | N/A | N/A | N/A | -23.9 |
| P/FCF | 13.3 | 23.8 | 33.2 | 24.3 | 39.6 | 39.3 | N/A | 80.5 | N/A | N/A | 212.7 | 34.1 | 44.9 |
| EV/EBIT | N/A | N/A | N/A | N/A | 75.7 | 51.0 | N/A | N/A | 0.8 | N/A | N/A | N/A | N/A |
| Price/Book | 1.0 | 1.0 | 1.6 | 3.3 | 3.4 | 2.3 | 2.8 | 5.9 | 1.0 | 1.3 | 1.5 | 0.8 | 0.8 |
| Price/Sales | 6.3 | 7.3 | 5.1 | 12.0 | 3.2 | 3.0 | 7.8 | 11.9 | N/A | 4.7 | 5.2 | 2.9 | 2.3 |
| FCF Yield | 7.5% | 4.2% | 3.0% | 4.1% | 2.5% | 2.5% | -0.1% | 1.2% | -16.2% | -1.0% | 0.5% | 2.9% | 2.2% |
| Market Cap | 643M | 657M | 886M | 2.0B | 2.4B | 2.6B | 3.4B | 7.8B | 3.3B | 3.2B | 2.6B | 1.3B | 1.4B |
| Avg. Price | 8.88 | 10.27 | 10.17 | 20.47 | 28.60 | 32.20 | 40.89 | 82.10 | 82.19 | 48.70 | 55.86 | 37.62 | 30.18 |
| Year-End Price | 9.43 | 9.70 | 12.89 | 28.87 | 34.09 | 36.34 | 46.00 | 105.16 | 44.42 | 49.57 | 49.38 | 28.56 | 30.18 |
Azenta, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
On a free-cash-flow basis, the stock trades at 44.9x vs a median of 36.7x. The company's 5-year average ROIC is 0.3% with a gross margin of 45.2%. At current prices, the estimated annualized return to fair value is +2.5%.
Azenta, Inc. (AZTA) has a 5-year average return on invested capital (ROIC) of 0.3%. This is below average and may indicate limited pricing power.
Azenta, Inc. (AZTA) has a market capitalization of $1.4B. It is classified as a small-cap stock.
Azenta, Inc. (AZTA) does not currently pay a regular dividend.
Azenta, Inc. (AZTA) operates in the Special Industry Machinery, Nec industry, within the Industrials sector.
Azenta, Inc. (AZTA) reported annual revenue of $594 million in its most recent fiscal year, based on SEC EDGAR filings.
Azenta, Inc. (AZTA) has a net profit margin of -9.4%. The company is currently unprofitable.
Azenta, Inc. (AZTA) generated $38 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
| -539M |
| 97M |
| ROIC | -2.2% | -3.3% | -3.3% | -0.5% | - | 8.4% |
|---|
| Gross Margin | 44.6% | 45.5% | 44.4% | 43.4% | - | 47.5% |
|---|
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
|---|
| Dividends/Share | $0.00 | - | $0.00 | $0.00 | $0.10 | $0.40 |
|---|
| Operating Income | -23M | -27M | -51M | -61M | - | -31M |
|---|
| Operating Margin | -3.8% | -4.5% | -8.9% | -11.1% | - | -6.1% |
|---|
| ROE | -3.4% | -3.3% | -7.8% | -0.5% | 91.0% | 8.7% |
|---|
| Shares Outstanding | 46M | 46M | 53M | 67M | 75M | 74M |
|---|
Azenta, Inc. (AZTA) has a debt-to-equity ratio of 0.00. This indicates a conservatively financed balance sheet.
Azenta, Inc. (AZTA) reported earnings per share (EPS) of $-1.22 in its most recent fiscal year.
Azenta, Inc. (AZTA) has a return on equity (ROE) of -3.3%. A negative ROE may indicate losses or negative equity.
Azenta, Inc. (AZTA) has a 5-year average gross margin of 45.2%. This indicates decent pricing power.
The Ledger Terminal provides 15 years of financial data for Azenta, Inc. (AZTA), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Azenta, Inc. (AZTA) has a book value per share of $37.09, based on its most recent annual SEC filing.